Elucidating the transactivation domain of the pleiotropic transcription factor Myrf

Area of Science:

• Molecular Biology
• Gene Regulation
• Protein Function

Background:

• Myrf is a novel type-II membrane protein functioning as a transcription factor across diverse species.
• Myrf undergoes auto-cleavage in the endoplasmic reticulum (ER) to release its N-terminal fragment for nuclear translocation and transcriptional activation.
• The specific domain responsible for Myrf's transactivation activity remains largely uncharacterized.

Purpose of the Study:

• To identify the transactivation domain of Myrf.
• To investigate the regulatory mechanisms affecting Myrf's transcriptional activity, specifically focusing on post-translational modifications.

Main Methods:

• Functional assays using Gal4 fusion proteins to test the transactivation potential of Myrf domains.
• Analysis of Myrf N-terminal fragment stability and nuclear localization.
• Site-directed mutagenesis to identify key lysine residues involved in sumoylation and assess its impact on function.

Main Results:

• The N-terminal-most (NTM) domain of Myrf was identified as the transactivation domain, capable of activating transcription independently of homo-trimerization.
• Sumoylation of the NTM domain was observed at three lysine residues (K123, K208, K276), with K276 being the primary site.
• Sumoylation at K276 significantly repressed the transactivation function of the NTM domain without altering protein stability or nuclear import.

Conclusions:

• The NTM domain is the primary transactivation domain of Myrf.
• K276 sumoylation acts as a negative regulator of Myrf's transcriptional activity, providing a novel mechanism for controlling gene expression.
• This study elucidates key aspects of Myrf function and regulation, relevant to its role in diverse organisms.